U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...

Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) ...

Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an ...

A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...

Sickle cell disease is a painful, inherited condition that primarily impacts African Americans. Dr. Sharl Azar, medical ...

Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major ...

On Friday, Sept. 27, lawmakers reintroduced the Sickle Cell Disease Treatment Centers Act. If passed, this bicameral bill ...

The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, ...

September is sickles cell awareness month. One Chicago woman who was diagnosed at birth is raising funds and awareness with a ...

Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 ...

About 100,000 Americans, mostly Black, have sickle cell disease, shortening lifespans, delaying puberty, damaging spleens and ...

Meanwhile, in Lawton, about a dozen people showed up at the Abundant Life Christian Church to donate blood for the Sickle ...